Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization?
about
Animal models of age related macular degenerationImproved assessment of laser-induced choroidal neovascularizationInfluence of Dll4 via HIF-1α-VEGF signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions.Comparison of long-acting bevacizumab formulations in the treatment of choroidal neovascularization in a rat model.A potential therapeutic strategy for inhibition of ocular neovascularization with a new endogenous protein: rhEDI-8t.Effect of intravitreal anti-vascular endothelial growth factor treatment on the retinal gene expression in acute experimental central retinal vein occlusion.Effects of intravitreal injection of KH902, a vascular endothelial growth factor receptor decoy, on the retinas of streptozotocin-induced diabetic rats.Effects of rat anti-VEGF antibody in a rat model of corneal graft rejection by topical and subconjunctival routes.Intravitreal tanibirumab, a fully human monoclonal antibody against vascular endothelial growth factor receptor 2, partially suppresses and regresses laser-induced choroidal neovascularization in a rat modelExtra cellular matrix derived metabolite regulates angiogenesis by FasL mediated apoptosisA Quantitative and Standardized Method for the Evaluation of Choroidal Neovascularization Using MICRON III Fluorescein Angiograms in Rats.Topical application of a G-Quartet aptamer targeting nucleolin attenuates choroidal neovascularization in a model of age-related macular degeneration.In Vivo Efficacy of an Injectable Microsphere-Hydrogel Ocular Drug Delivery System.FAK and p38-MAP kinase-dependent activation of apoptosis and caspase-3 in retinal endothelial cells by alpha1(IV)NC1Biocompatible reverse thermal gel sustains the release of intravitreal bevacizumab in vivo.Pharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGF.Cubosomes and other potential ocular drug delivery vehicles for macromolecular therapeutics.The impact of subconjuctivally injected EGF and VEGF inhibitors on experimental corneal neovascularization in rat model.Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model.Anti-VEGFs hinder bone healing and implant osseointegration in rat tibiae.Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumabInhibitory effect of intravitreal injection of bevacizumab on nerve growth factor.
P2860
Q27004686-DF5B2D15-BF6E-4D8C-ACC4-A1E98E01AC65Q33606410-A1241910-B851-4823-8888-C2868E79639DQ33883649-A72D5BEF-E9DA-4CD9-BA23-CEF623FC6539Q33901283-6DA7BB48-7174-463C-89A9-97E2659FC25CQ34007035-8CFBF135-223F-49D1-963B-8AB032AD77C8Q34083555-35400657-8952-4260-A06E-E53D11BD13E8Q34160549-BC704290-1E59-443C-B6E1-A5FB0F11F243Q34493789-9C359574-DA07-4A97-8EE8-B1C0CA6E23A6Q34652557-5686D2AE-A6E3-4482-9914-1A09F801ED62Q35063753-01FBD281-A194-4A08-B9D3-5F9A732301CDQ35646181-E7B12A88-BBE6-429B-80E1-304DE58D88EBQ35774515-F1C23BB6-2481-446F-A15C-6DCBD6D96FA3Q36384759-36F2E834-881E-40D7-AD21-0AFC48D55E05Q37482353-6F70DB6F-583E-4185-8B24-264A98C12E65Q37513330-3EFE5B2A-45AF-4331-B181-0106ECE0E46BQ38183850-1CDF2AA8-C79F-439A-8119-3C6B7B589D04Q38368715-A6740D78-1EF1-49CC-8E30-A2C39E9F8FE4Q40002867-8573DDB0-7B28-49CE-A81A-BCAB1A2F1290Q40023737-0B433C4D-B2EA-4E0D-B6DA-57E54E4DD80EQ40836798-68BA7352-9065-4222-BCBE-7E6C343C140FQ42139247-8D56DEA3-8AE7-434F-BD99-790118C8D716Q54341588-20EA8418-7870-488B-9592-846996F029E9
P2860
Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization?
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Are intravitreal bevacizumab a ...... choroidal neovascularization?
@ast
Are intravitreal bevacizumab a ...... choroidal neovascularization?
@en
type
label
Are intravitreal bevacizumab a ...... choroidal neovascularization?
@ast
Are intravitreal bevacizumab a ...... choroidal neovascularization?
@en
prefLabel
Are intravitreal bevacizumab a ...... choroidal neovascularization?
@ast
Are intravitreal bevacizumab a ...... choroidal neovascularization?
@en
P1476
Are intravitreal bevacizumab a ...... choroidal neovascularization?
@en
P2093
Ron A Adelman
P2860
P2888
P304
P356
10.1007/S00417-008-0936-Y
P577
2008-09-10T00:00:00Z
P6179
1001312471